Cytodyn, Inc.
Records under this name other than the patents Cytodyn, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,821,877 | Methods for Inhibiting HIV-1 Replication Involving the Administration of an ANTI-CCR5 Receptor Monoclonal Antibody and Small Molecule CCR5 Receptor Antagonist. Term ended Term ended Jul 21, 2026 · High confidence | Term ended | Term ended Jul 21, 2026 | High confidence |
| US 11,045,546 | Methods of treating coronavirus infection Formerly held Lapsed on the fee record Ended Jun 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 29, 2025 | From the USPTO record |
| US 7,122,185 | ANTI-CCR5 Antibody Formerly held Term ended Term ended Jun 1, 2024 · High confidence | Term ended | Term ended Jun 1, 2024 | High confidence |
| US 10,562,969 | Substitution monotherapy treatment for HIV-1 infection employing antibody PRO140 Lapsed on the fee record Ended Feb 18, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 18, 2024 | From the USPTO record |
| US 10,500,274 | Methods for reducing viral load in HIV-1 infected patients Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 7,666,419 | ANTI-CCR5 Antibody Formerly held Term ended Term ended Feb 21, 2023 · High confidence | Term ended | Term ended Feb 21, 2023 | High confidence |
| US 7,851,600 | ANTI-CCR5 Antibody Formerly held Lapsed on the fee record Ended Dec 14, 2022 · High confidence | Lapsed on the fee record | Ended Dec 14, 2022 | High confidence |
| US 7,060,273 | Methods for Inhibiting HIV-1 Infection Term ended Ended no later than Nov 19, 2022 · Medium confidence | Term ended | Ended no later than Nov 19, 2022 | Medium confidence |
| US 7,138,119 | Compositions and Methods for Inhibition of HIV-1 Infection Term ended Term ended Nov 1, 2022 · Medium confidence | Term ended | Term ended Nov 1, 2022 | Medium confidence |
| US 9,499,621 | Felinized antibodies and methods of treating retroviral infections in felines Lapsed on the fee record Ended Nov 22, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2020 | From the USPTO record |